FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Monday

 

Designing epidemiologic study for MS and other neurologic diseases in Gulf War Vets



















Image Source: PINTEREST

The U.S. Department of Veterans Affairs (VA) requested that the National Academies of Sciences, Engineering, and Medicine conduct a study to respond to Public Law 110-389 to determine the incidence, prevalence, and risk of developing multiple sclerosis and other neurologic diseases -- including migraines, Parkinson's disease, brain cancers, and central nervous system abnormalities difficult to diagnose precisely -- as a result of service in the 1990-1991 Persian Gulf and post 9/11 Global Operations theaters.

In a new Academies report, Considerations for Designing an Epidemiologic Study for Multiple Sclerosis and Other Neurologic Disorders in Pre and Post 9/11 Gulf War Veterans, the committee convened to carry out the study concluded that while technically feasible, it would not continue with the next steps of designing and implementing a study of the neurologic diseases of concern. The primary reason for the committee's conclusion was the restriction to using only existing VA data for its work. Furthermore, VA and numerous other researchers have already published results on the outcomes of concern using VA data linked to other data sources, and therefore, it is unlikely that the committee would find different results from those well-designed studies that already have been published and scrutinized. Given that the committee would be limited to using existing VA data only, an Academies study would essentially repeat the work of others, yet have the additional limitation of not having access to other important data sources. Thus, the committee did not believe it could advance the knowledge significantly beyond what is already known.

Story Source: The above story is based on materials provided by NEWS-MEDICAL
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News